BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 167571)

  • 21. Comparison of clinical and experimental data from an animal model of pulmonary immunologic sensitivity.
    Karol MH
    Ann Allergy; 1991 Jun; 66(6):485-9. PubMed ID: 1646579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of repeated CO2 challenges to evaluate the pulmonary performance of guinea pigs exposed to toluene diisocyanate.
    Wong KL; Karol MH; Alarie Y
    J Toxicol Environ Health; 1985; 15(1):137-48. PubMed ID: 2984437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of chemical-specific IgG antibodies in male workers from a urethane foam factory.
    Tsuji M; Ishihara Y; Isse T; Koriyama C; Yamamoto M; Kakiuchi N; Yu HS; Tanaka M; Tsuchiya T; Ohta M; Tanaka R; Kawamoto T
    Environ Health Prev Med; 2018 Jun; 23(1):24. PubMed ID: 29921217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Occupational asthma, lung function decrement, and toluene diisocyanate (TDI) exposure: a critical review of exposure-response relationships.
    Ott MG
    Appl Occup Environ Hyg; 2002 Dec; 17(12):891-901. PubMed ID: 12495600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experimental model of asthma by toluene diisocyanate (TDI).
    Tanaka K; Kawai M; Maekawa N
    Bull Chest Dis Res Inst Kyoto Univ; 1983 Mar; 16(1-2):1-9. PubMed ID: 6317089
    [No Abstract]   [Full Text] [Related]  

  • 26. An epidemiologic investigation of forced expiratory volume at 1 second and respiratory symptoms among employees of a toluene diisocyanate production plant.
    Olsen GW; Shellenberger R; Bodner KM; Flores GH; Emmitte JA; Bond GG; Saunders JH
    J Occup Med; 1989 Aug; 31(8):664-7. PubMed ID: 2547915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal study of tolyl-reactive IgE antibodies in workers hypersensitive to TDI.
    Karol MH; Sandberg T; Riley EJ; Alarie Y
    J Occup Med; 1979 May; 21(5):354-8. PubMed ID: 224155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical, immunologic, and physiologic observations in factory workers exposed to B. subtilis enzyme dust.
    Franz T; McMurrain KD; Brooks S; Bernstein IL
    J Allergy; 1971 Mar; 47(3):170-80. PubMed ID: 4994061
    [No Abstract]   [Full Text] [Related]  

  • 29. Differences of opinion over TDI.
    Hopkins J
    Food Cosmet Toxicol; 1980 Apr; 18(2):199. PubMed ID: 6248443
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunologic sensitization and pulmonary hypersensitivity by repeated inhalation of aromatic isocyanates.
    Karol MH; Dixon C; Brady M; Alarie Y
    Toxicol Appl Pharmacol; 1980 Apr; 53(2):260-70. PubMed ID: 6249000
    [No Abstract]   [Full Text] [Related]  

  • 31. Long-term effects on the health of men engaged in the manufacture of tolylene di-isocyanate.
    Adams WG
    Br J Ind Med; 1975 Feb; 32(1):72-8. PubMed ID: 164881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methods for the identification of chemical respiratory allergens in rodents: comparisons of cytokine profiling with induced changes in serum IgE.
    Dearman RJ; Skinner RA; Humphreys NE; Kimber I
    J Appl Toxicol; 2003; 23(4):199-207. PubMed ID: 12884401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of respiratory hypersensitivity in guinea pigs sensitized to toluene diisocyanate: improvements on analysis of respiratory response.
    Pauluhn J
    Fundam Appl Toxicol; 1997 Dec; 40(2):211-9. PubMed ID: 9441717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Five-year longitudinal study of workers employed in a new toluene diisocyanate manufacturing plant.
    Robins J; Greaves IA; Eisen EA
    Am Rev Respir Dis; 1983 Aug; 128(2):327-8. PubMed ID: 6309046
    [No Abstract]   [Full Text] [Related]  

  • 35. Five-year longitudinal study of workers employed in a new toluene diisocyanate manufacturing plant.
    Diem JE; Jones RN; Hendrick DJ; Glindmeyer HW; Dharmarajan V; Butcher BT; Salvaggio JE; Weill H
    Am Rev Respir Dis; 1982 Sep; 126(3):420-8. PubMed ID: 6289703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic factors for toluene diisocyanate-induced occupational asthma after removal from exposure.
    Park HS; Nahm DH
    Clin Exp Allergy; 1997 Oct; 27(10):1145-50. PubMed ID: 9383254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Seroimmunological characteristics of Korean workers exposed to toluene diisocyanate.
    Kim H; Kim YD; Choi J
    Environ Res; 1997 Oct; 75(1):1-6. PubMed ID: 9356188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diisocyanate emission from a paint product: a preliminary analysis.
    Jarand CW; Akapo SO; Swenson LJ; Kelman BJ
    Appl Occup Environ Hyg; 2002 Jul; 17(7):491-4. PubMed ID: 12083169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiology of toluene diisocyanate (TDI)-induced respiratory disease.
    Peters JM; Wegman DH
    Environ Health Perspect; 1975 Jun; 11():97-100. PubMed ID: 170078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of air-purifying respirators for protection against toluene diisocyanate vapors.
    Dharmarajan V; Lingg RD; Hackathorn DR
    Am Ind Hyg Assoc J; 1986 Jul; 47(7):393-8. PubMed ID: 3019117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.